Is long-term administration of PLD-pegylated liposomal doxorubicin able to induce oral cancer?
Crossref DOI link: https://doi.org/10.1007/s10495-024-02017-5
Published Online: 2024-09-06
Published Print: 2024-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pandian, Arjun
Sivalingam, Azhagu Madhavan
Text and Data Mining valid from 2024-09-06
Version of Record valid from 2024-09-06
Article History
Accepted: 1 September 2024
First Online: 6 September 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.